LOADING

Type to search

Supporting Your Practice

Revisiting Burning Mouth Syndrome

This summary is based on the article published in Dental Clinics of North America

Neurologic Disorders of the Maxillofacial Region

Burning mouth syndrome (BMS) presents as an unexplained pain, dysesthesia, or burning in a clinically normal and healthy oral mucosa.1, 2 A diagnosis is made if the symptoms recur daily for more than 2 h/d and for at least 3 months as per the definition from the Committee of the International Headache Society.3 It is a diagnosis of exclusion, and other systemic, local medical or dental sources of pain must be ruled out.4

  1. Zakrzewska JM. Facial pain: an update. Curr Opin Support Palliat Care 2009;3: 125–30.
  2. Buchanan J, Zakrzewska J. Burning mouth syndrome. BMJ Clin Evid 2008;1301.
  3. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013;33:629–808.
  4. Klasser GD, Grushka M, Su N. Burning mouth syndrome. Oral Maxillofac Surg Clin North Am 2016;28:381–96.

Topical or systemic pharmacologic agents have been successful in managing or distracting some patients with BMS. These agents include alpha lipoic acid, low-dose clonazepam, which should be discontinued with caution as a result of associated withdrawal syndrome (suicidal tendencies); topical capsaicin; gabapentin; amitriptyline; and doxepin. Other treatment strategies used are low-level laser therapy, stress, and behavioral management.

We always look forward to hearing your thoughts and receiving your questions and/or suggestions about this post and other topics. Leave a comment in the box below or send us your feedback by email.

Until next time!
CDA Oasis Team

 

Leave a Comment

Your email address will not be published. Required fields are marked *